The Role of β-Transducin Repeat-Containing Protein (β-TrCP) in the Regulation of NF-κB in Vascular Smooth Muscle Cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 1, 2004, Pages 85-90

  Wang, Xiaohong ^a   Adhikari, Neeta ^a   Li, Qinglu ^a   Guan, Zhanjun ^a   Hall, Jennifer L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

catenin; TrCP1; Muscle, vascular, smooth; Nuclear factor B; Wnt

Indexed keywords

BETA CATENIN; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; CELL PROTEIN; F BOX PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 PROTEIN;

ANIMAL CELL; ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENE; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BETA CATENIN; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; CELLS, CULTURED; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; LEUPEPTINS; LITHIUM CHLORIDE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; RATS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 0345861767     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000104012.40720.c4     Document Type: Article

References (42)

1. Collins T, Cybulsky MI. NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest. 2001;107:255-264.
2. de Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-κB and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000;20:E83-E88.
3. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372-377.
4. Heyninck K, Beyaert R. Crosstalk between NF-κB-activating and apoptosis-inducing proteins of the TNF-receptor complex. Mol Cell Biol Res Commun. 2001;4:259-265,
5. Karin M. Ben Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000;18:621-663.
6. Rothwarf DM, Karin M. The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus, Sci STKE. 1999;1999:RE1.
7. Maniatis T. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev. 1999;13:505-510.
8. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben Neriah Y. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1995;92:10599-10603.
9. Ben Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol. 2002;3:20-26.
10. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science. 1995;267:1485-1488.
11. Lin YC, Brown K, Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc Nart Acad Sci USA. 1995;92:552-556.
12. Spencer E, Jiang J, Chen ZJ. Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP. Genes Dev. 1999;13:284-294.
13. Yaron A, Hatzubai A, Davis M, Lavon I, Amit S, Manning AM, Andersen JS, Mann M, Mercurio F, Ben Neriah Y. Identification of the receptor component of the IκBα-ubiquitin ligase. Nature. 1998;396:590-594.
14. Kroll M, Margottin F, Kohl A, Renard P, Durand H, Concordet JP, Bachelerie F, Arenzana-Seisdedos F, Benarous R. Inducible degradation of IκBα by the proteasome requires interaction with the F-box protein h-βTrCP. J Biol Chem. 1999;274:7941-7945.
15. Suzuki H, Chiba T, Kobayashi M, Takeuchi M, Suzuki T, Ichiyama A, Ikenoue T, Omata M, Furuichi K, Tanaka K. IκBα ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, βTrCP1 and βTrCP2. Biochem Biophys Res Commun. 1999;256:127-132.
16. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 1999;13:270-283.
17. Adams J. Development of the proteasome inhibitor PS-341. Oncologist. 2002;7:9-16.
18. Grisham MB, Palombella VJ, Elliott PJ, Conner EM, Brand S, Wong HL, Pien C, Mazzola LM, Destree A, Parent L, Adams J. Inhibition of NF-κB activation in vitro and in vivo: role of 26S proteasome. Methods Enzymol. 1999;300:345-363.
19. Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs SY. Wnt/β-catenin signaling induces the expression and activity of βTrCP ubiquitin ligase receptor. Mol Cell. 2000;5:877-882.
20. Spiegelman VS, Stavropoulos P, Latres E, Pagano M, Ronai Z, Slaga TJ, Fuchs SY. Induction of β-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-κB. J Biol Chem. 2001;276:27152-27158.
21. Barker N, Morin PJ, Clevers H. The yin-yang of TCF/β-catenin signaling. Adv Cancer Res. 2000;77:1-24.
22. Hecht A, Litterst CM, Huber O, Kemler R. Functional characterization of multiple transactivating elements in β-catenin, some of which interact with the TATA-binding protein in vitro. J Biol Chem. 1999;274:18017-18025.
23. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL. A role for the β-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res. 2002;90:340-347.
24. Hetman M, Cavanaugh JE, Kimelman D, Xia Z. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal. J Neurosci. 2000;20:2567-2574.
25. Kolligs FT, Hu G, Dang CV, Fearon ER. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol. 1999;19:5696-5706.
26. -/- colon carcinoma. Science. 1997;275:1784-1787.
27. Hall JL, Wang X, Van A, Zhao Y, Gibbons GH. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-κB-independent and -dependent pathways. Circ Res. 2001;88:1247-1253.
28. Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-κB and its inhibitor, IκB. J Biol Chem. 2000;275:883-889.
29. Obara H, Takayanagi A, Hirahashi J, Tanaka K, Wakabayashi G, Matsumoto K, Shimazu M, Shimizu N, Kitajima M. Overexpression of truncated IκBα induces TNF-α-dependent apoptosis in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000;20:2198-2204.
30. Bourcier T, Sukhova G, Libby P. The nuclear factor-κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 1997;272:15817-15824.
31. Jiang B, Xu S, Brecher P, Cohen RA. Growth factors enhance interleukin-1 β-induced persistent activation of nuclear factor-κB in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2002;22:1811-1816.
32. Spevak W, Keiper BD, Stratowa C, Castanon MJ. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with β-transducin repeats. Mol Cell Biol. 1993;13:4953-4966.
33. Fuchs SY, Chen A, Xiong Y, Pan ZQ, Ronai Z. HOS. a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin. Oncogene. 1999;18:2039-2046.
34. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA. Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem. 2002;277:38239-38244.
35. Davis M, Hatzubai A, Andersen JS, Ben Shushan E, Fisher GZ, Yaron A, Bauskin A, Mercurio F, Mann M, Ben Neriah Y. Pseudosubstrate regulation of the SCF(β-TrCP) ubiquitin ligase by hnRNP-U. Genes Dev. 2002;16:439-451.
36. Lassot I, Segeral E, Berlioz-Torrent C, Durand H, Groussin L, Hai T, Benarous R, Margottin-Goguet F. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(βTrCP) ubiquitin ligase. Mol Cell Biol. 2001;21:2192-2202.
37. Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY, Hung MC. β-Catenin interacts with and inhibits NF-κB in human colon and breast cancer. Cancer Cell. 2002;2:323-334.
38. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, Gaynor RB. Regulation of β-catenin function by the IκB kinases. J Biol Chem. 2001;276:42276-42286.
39. Masui O, Ueda Y, Tsumura A, Koyanagi M, Hijikata M, Shimotohno K. Re1A suppresses the Wnt/β-catenin pathway without exerting trans-acting transcriptional ability. Int J Mol Med. 2002;9:489-493.
40. Suzuki H, Chiba T, Suzuki T, Fujita T, Ikenoue T, Omata M, Furuichi K. Shikama H, Tanaka K. Homodimer of two F-box proteins βTrCP1 or βTrCP2 binds to IκBα for signal-dependent ubiquitination. J Biol Chem. 2000;275:2877-2884.
41. Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, Donzelli M, Margottin-Goguet F, Jackson PK, Yamasaki L, Pagano M. Control of meiotic and mitotic progression by the F box protein β-Trcp1 protein in vivo. Dev Cell 2003;4:799-812.
42. Nakayama K, Hatakeyama S, Maruyama S, Kikuchi A, Onoe K, Good RA, Nakayama KI. Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene. Proc Natl Acad Sci U S A. 2003;100:8752-8757.